Sangamo Therapeutics, Inc. (SGMO) NASDAQ
0.30
+0.04(+15.38%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.30
+0.04(+15.38%)
Currency In USD
| Market Cap | 117.68M |
| Enterprise Value | 121.83M |
| P/E Ratio | -0.82 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 2.82 |
| Price/Book Ratio | -7.1 |
| Enterprise/Revenue | 2.92 |
| Enterprise/EBITDA | -0.99 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -3.11 |
| Operating Margin | -3.07 |
| Return On Assets | -2.06 |
| Return On Equity | -29.83 |
| Revenue | 39.55M |
| Revenue/Share | 0.12 |
| Gross Profit | 0 |
| EBITDA | -121.24M |
| Net Income | -122.93M |
| Diluted EPS | -0.44 |
| Total Cash | 20.95M |
| Total Cash/Share | 0.06 |
| Total Debt | 25.09M |
| Total Debt/Equity | -1.76 |
| Current Ratio | 0.84 |
| Book Value Per Share | -0.04 |
| 52-Week Change | -51.78 |
| 52-Week High | 0.84 |
| 52-Week Low | 0.21 |
| Moving Average 50 Days | 0.39 |
| Moving Average 200 Days | 0.49 |
| Average Volume | 6.61M |
| Shares Outstanding | 371.68M |
| % Held by Institutions | 20.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |